- Home
- HXHX vs HOTH Comparison
HXHX vs HOTH Comparison
Compare HXHX & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HXHX
- HOTH
- Stock Information
- Founded
- HXHX 2003
- HOTH 2017
- Country
- HXHX China
- HOTH United States
- Employees
- HXHX N/A
- HOTH N/A
- Industry
- HXHX Trucking Freight/Courier Services
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- HXHX Industrials
- HOTH Health Care
- Exchange
- HXHX Nasdaq
- HOTH Nasdaq
- Market Cap
- HXHX 19.0M
- HOTH 15.6M
- IPO Year
- HXHX 2025
- HOTH 2019
- Fundamental
- Price
- HXHX $1.24
- HOTH $1.31
- Analyst Decision
- HXHX
- HOTH Strong Buy
- Analyst Count
- HXHX 0
- HOTH 3
- Target Price
- HXHX N/A
- HOTH $4.00
- AVG Volume (30 Days)
- HXHX 86.4K
- HOTH 421.5K
- Earning Date
- HXHX 01-01-0001
- HOTH 05-12-2025
- Dividend Yield
- HXHX N/A
- HOTH N/A
- EPS Growth
- HXHX N/A
- HOTH N/A
- EPS
- HXHX 0.26
- HOTH N/A
- Revenue
- HXHX $25,571,810.00
- HOTH N/A
- Revenue This Year
- HXHX N/A
- HOTH N/A
- Revenue Next Year
- HXHX N/A
- HOTH N/A
- P/E Ratio
- HXHX $5.10
- HOTH N/A
- Revenue Growth
- HXHX N/A
- HOTH N/A
- 52 Week Low
- HXHX $1.11
- HOTH $0.58
- 52 Week High
- HXHX $6.29
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- HXHX N/A
- HOTH 51.27
- Support Level
- HXHX N/A
- HOTH $1.21
- Resistance Level
- HXHX N/A
- HOTH $1.41
- Average True Range (ATR)
- HXHX 0.00
- HOTH 0.10
- MACD
- HXHX 0.00
- HOTH -0.01
- Stochastic Oscillator
- HXHX 0.00
- HOTH 41.30
About HXHX Haoxin Holdings Limited Class A Ordinary Shares
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).